Integra LifeSciences Cor...

NASDAQ: IART · Real-Time Price · USD
13.62
-0.50 (-3.54%)
At close: Aug 14, 2025, 3:59 PM
13.63
0.07%
Pre-market: Aug 15, 2025, 07:18 AM EDT

Integra LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.61B 1.54B 1.56B 1.54B
Cost of Revenue
728.47M 653.18M 587.36M 597.81M
Gross Profit
882.06M 888.39M 970.31M 944.64M
Operating Income
28.41M 111.53M 238.92M 197.23M
Interest Income
20.04M 17.2M 11.92M 6.74M
Pretax Income
-18.24M 81.07M 213.89M 214.68M
Net Income
-6.94M 67.74M 180.55M 169.07M
Selling & General & Admin
665.53M 592.64M 616.32M 637.45M
Research & Development
115.38M 174.59M 101.19M 93.05M
Other Expenses
21.29M 69.16M 13.88M 16.91M
Operating Expenses
853.65M 836.39M 731.39M 747.41M
Interest Expense
70.63M 51.38M 49.59M 50.4M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.58B 1.43B 1.32B 1.35B
Income Tax Expense
-11.29M 13.33M 33.34M 45.6M
Shares Outstanding (Basic)
77.01M 78.17M 83M 84.7M
Shares Outstanding (Diluted)
77.01M 80.34M 83.52M 85.48M
EPS (Basic)
-0.09 0.87 2.18 2.00
EPS (Diluted)
-0.09 0.84 2.16 1.98
EBITDA
193.29M 274.01M 391.1M 366.33M
EBIT
52.4M 132.45M 263.49M 242.66M
Depreciation & Amortization
140.5M 123.51M 121.11M 123.67M